• September 21-22, Bethesda, MD

    10th Annual AMIA Policy Invitational

    Completing the Evidence Cycle

    Reimagining the Research-Practice Relationship in the Post-Meaningful Use Era

2016 Annual Health Policy Invitational Meeting

September 21 - 22, 2016

Completing the Evidence Cycle: Reimagining the Research-Practice Relationship in a Post-Meaningful Use Era

Policy Invitational Steering Committee Chair: Peter Embi, M.D., M.S. FACMI

For the last decade, the AMIA Policy Invitational has served as a unique platform to inform legislative, regulatory, and policy development.  During the 2016 AMIA Policy Invitational (API2016) participants will participate with colleagues in focused and thought-provoking discussions that will help articulate recommendations for the new Administration and 115th Congress.

The theme of this year’s Invitational looks at the possibilities and the pitfalls of reaching near universal adoption of EHRs in US healthcare, and how this paradigm requires a re-examination of how clinical practice interacts with clinical research and vice versa.  API2016 will feature three keynote speakers, including: 

Dr. Robert M. Califf, Commission of the Food & Drug administration


Dr. Patricia Flatley Brennan, Director of the National Library of Medicine 


Dr. Andrew B. Bindman, Director of the Agency for Healthcare Research & Quality


The increasing overlap between clinical research and practice necessitates a broad discussion of how we can leverage point-of-care activities and systems to improve clinical research, accelerate biomedical discovery and improve the health of individuals and populations.

Attendees will participate in multi-stakeholder breakout sessions where they will engage with their peers in facilitated discussions meant to develop concrete, actionable recommendations on the topics of "Nodes: Evidence Generation at the Local Level," "Networks: Clinical Research Across Organizations," and "Sustainability: Maintaining a National Research Ecosystem."

Given the ascendance of a new Administration and 115th Congress in 2017, recommendations developed through API2016 will develop solutions-oriented ideas to the fast-moving legislative and regulatory environment – in Washington, DC and beyond.

As a supplement to API2016, AMIA is partnering with the newly established North American Center for the Study of Ethics and Health Information Technology to host an afternoon of dialogue and idea-sharing September 22.  The Center, established by bioethics institutes at the University of Miami and Indiana University medical schools, will host, "Ethics and Informatics: Challenges, Prospects, Solutions," which will include panels on both domestic and international perspectives.  Special guests include bioethics experts from the White House, World Health Organization, and the Office of the National Coordinator.

Program

September 21, 2016

7:30 am Registration and Continental Breakfast
8:15 – 8:45 am Welcome and Opening Remarks
  • Thomas Payne, M.D., Ph.D, Chair, AMIA Board of Directors
  • Peter Embi, M.D., M.S., Policy Invitational Chair
8:45 – 9:45 am Keynote (plus Q&A)
  • Patricia Flatley Brennan, R.N., Ph.D., Director of the National Library of Medicine
9:45 – 10:00 am Explanation of Breakouts / Instructions
10:15 – 11:15 am Breakout Session One
  • Nodes: Evidence Generation at the Local Level – What will it take to leverage current activities and existing systems for research at the local level?
11:15 – 11:30 am  Break 
11:30 am – 12:15 pm Reports from Breakout Session 1 (Panel-Style, Moderated)
12:15  – 1:00 pm Networking Lunch
1:15 – 2:15 pm Breakout Session Two
  • Networks: Clinical Research across Organizations – What policies and strategies are needed to facilitate research across organizations and networks?
2:15 – 2:30 pm Break
2:30 – 3:15 pm Reports from Breakout Session 2 (Panel-Style, Moderated)
3:30 – 4:30 pm Keynote (plus Q&A)
  • Robert M. Califf, M.D., Commissioner of the U.S. Food and Drug Administration
4:30 – 5:00 pm Day 1 Overview & Adjourn
  • Dr. Peter Embi, Policy Invitational Chair

September 22, 2016

7:30 am Breakfast
8:00 – 8:15 am Welcome and Day 1 Review
  • Dr. Peter Embi, Policy Invitational Chair
8:15 – 9:15 am Keynote (plus Q&A)
  • Andrew B. Bindman, M.D., Director of the Agency on Healthcare Research & Quality
9:15 – 9:30 am Break
9:30 – 10:30 am Breakout Session Three
  • Sustainability: Maintaining a National Research Ecosystem – What are the barriers to sustaining a national ecosystem of research networks?
10:30 – 11:15 am Reports from Breakout Session 3 (Panel-Style, Moderated)
11:15  – 11:45 am Review of Recommendations and Research Agenda, Next Steps
11:45 am – 12:00 pm Concluding Remarks and Acknowledgements
  • Dr. Peter Embi, Policy Invitational Chair
ETHICS AND INFORMATICS: CHALLENGES, PROSPECTS, SOLUTIONSA Special AMIA Workshop co-hosted by the North American Center for the Study of Ethics and Health Information Technology
12:30 pm Lunch Keynote
  • Elise Sweeney, J.D., Director of Policy, Office of the National Coordinator for Health IT
1:15 – 1:30 pm From Granular Control to Really, Really Big Data: The Role of Ethics in Practice, Policy and Research
  • Kenneth Goodman, Ph.D., Director, University of Miami Miller School of Medicine Institute for Bioethics and Health Policy
  • Peter Schwartz, M.D., Ph.D., Interim Director, Indiana University Center for Bioethics
1:30 – 2:30 pm Ethics, Informatics, Policy, Education (Panel)
  • Andrew Gettinger, M.D., Chief Medical Information Officer, Executive Director, Office of Clinical Quality and Safety, Office of the National Coordinator for Health IT
  • Lisa M. Lee, Ph.D., M.A., M.S., Executive Director of the Presidential Commission for the Study of Bioethical Issues
  • Peter Embi, M.D., M.S., Associate Professor and Vice-Chair, Department of Biomedical Informatics, The Ohio State University
  • Douglas B. Fridsma, M.D., Ph.D., President & CEO, AMIA
2:30 – 3:30 pm International Perspectives and Partnerships (Panel)
  • Erika Judith Salinas de la Torre, Deputy Director General, National Bioethics Commission of Mexico
  • Carlisle George, LL.M., Ph.D., Director, Aspects of Law and Ethics Related to Technology (ALERT), Middlesex University School of Science & Technology, London
  • Kenneth Goodman, Ph.D., Director, University of Miami Miller School of Medicine Institute for Bioethics and Health Policy
3:30 pm Conclusion, Summary and Next Steps